---
title: Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?
nct_id: NCT03113097
overall_status: COMPLETED
phase: NA
sponsor: Ain Shams University
study_type: INTERVENTIONAL
primary_condition: Infertility
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03113097.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03113097"
ct_last_update_post_date: 2017-04-13
last_seen_at: "2026-05-12T06:06:57.813Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?

**NCT ID:** [NCT03113097](https://clinicaltrials.gov/study/NCT03113097)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 627
- **Lead Sponsor:** Ain Shams University
- **Collaborators:** Dar El Teb Institute
- **Conditions:** Infertility
- **Start Date:** 2014-06
- **Completion Date:** 2017-03
- **CT.gov Last Update:** 2017-04-13

## Brief Summary

Women planned to undergo blastocyst-stage embryo transfer after IVF/ICSI were randomized into 2 groups:

* group I: women who had only good-quality embryo transfer.
* group II: women who had both good-quality and poor-quality embryo transfer.

primary outcome was ongoing clinical pregnancy rate

## Eligibility

- **Minimum age:** 20 Years
- **Maximum age:** 35 Years
- **Sex:** FEMALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* women undergoing primary IVF/ICSI cycles for tubal factor/unexplained infertility and had blastocyst-stage ET

Exclusion Criteria:

* cleavage-stage ET.
* women who had no good-quality embryos to transfer
* women who had known poor endometrial receptivity
```

## Arms

- **Good-quality embryo transfer** (ACTIVE_COMPARATOR) — Women who had only good-quality embryo transfer
- **good- and poor-quality embryo transfer** (ACTIVE_COMPARATOR) — Women who had both good- and poor-quality embryo transfer

## Interventions

- **Embryo transfer** (OTHER) — Transfer of different qualities of embryos at blastocyst stage

## Primary Outcomes

- **Ongoing clinical pregnancy rate** _(time frame: 12 weeks)_ — viable intrauterine pregnancy ongoing beyond 12 weeks of gestation

## Secondary Outcomes

- **Biochemical pregnancy rate** _(time frame: 2 weeks after ET)_
- **Clinical pregnancy rate** _(time frame: 4 weeks after ET)_
- **Multiple pregnancy rate** _(time frame: 4-6 weeks after ET)_
- **Ectopic pregnancy rate** _(time frame: 6 weeks after ET)_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03113097.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03113097*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*